Despite a preliminary theory that health insurers could potentially hold too much buyer power, resulting in a loss of quality of consulting and preventative care for consumers, the Competition Commission has expressed support of health insurers in its most recent update of a widespread probe into the UK’s private healthcare sector. A common complaint, according to reports, often involves Bupa, one of the UK’s largest private medical insurers; the CC has received complaints that the insurer’s fee schedule reduces consultation quality and hinders innovation. The Commission has said it has “not seen evidence” of these claims, however. While its update did not come down hard on insurers, the Commission did suggest that there may be cause for concern within the private hospital operators’ sector.
Full Content: Health Investor
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Car Battery Makers to Challenge EU Cartel Charges in Brussels
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI